(Q51558091)
Statements
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. (English)
1 reference
Gomis R
1 reference
Squatrito S
1 reference
Jones NP
1 reference
Patwardhan RN
1 reference
1 January 2000
1 reference
17
1 reference
1
1 reference
40-47
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference